Sage Journals: Discover world-class research

Abstract

Background

Half of US adults have ≥1 cardiovascular disease (CVD) risk factors. Exercise is the first-line lifestyle therapy to prevent and treat CVD. We developed the Prioritize Personalize Prescribe Exercise algorithm (P3-EX), an evidence-based tool that clinicians can use to prescribe exercise for patients with CVD risk factors.

Purpose

To conduct a feasibility survey study of user satisfaction and usability of P3-EX as an exercise prescription (ExRx) tool among healthcare providers.

Methods

Healthcare providers enter information on the patient's medical history and CVD risk factors into P3-EX. Prioritize Personalize Prescribe Exercise algorithm then scores and prioritizes CVD risk factors and produces an ExRx for the prioritized CVD risk factor. We recruited physicians (N = 39), nurses (N = 63), and allied health professionals (N = 231) who recommend exercise to patients through professional society meetings, presentations, newsletters, and investigators’ networks. Participants completed a timed case study of a patient with CVD risk factors using P3-EX on a templated website. They then completed an adapted version of the Mobile Application Rating Scale, with responses ranging from 5 (completely agree) to 1 (completely disagree) to evaluate the ease of use, system information arrangement, and usefulness of P3-EX. Descriptive statistics determined the % response, time spent using P3-EX, and ExRx produced.

Results

Of the 844 recruited participants, 309 completed the feasibility survey study (healthcare provider N = 143, people with other professional affiliates N = 166). Of these, 86.9% agreed using P3-EX will make their patients healthier; 86.6% agreed feedback is immediate and understandable; 81.4% agreed P3-EX is intuitive, producing high-quality, evidenced-based, individualized ExRx; 83.5% are generally satisfied with P3-EX; 81.3% would recommend P3-EX to colleagues; and 79.2% agreed ExRx produced by P3-EX is safe. However, 34.4% agreed fault tolerance could be improved. Most participants (88.8%) produced an ExRx for the same prioritized CVD risk factor. The average time spent using P3-EX was 4.6 min.

Conclusion

We found healthcare providers are satisfied with P3-EX and agreed that it is a usable ExRx tool for patients with CVD risk factors. Our results are promising because healthcare providers lack the time, knowledge, confidence, and guidance to recommend exercise to patients. Prioritize Personalize Prescribe Exercise algorithm appears to be a potential solution to this problem.

Keywords

Digital health exercise cardiovascular disease hypertension diabetes chronic risk factors obesity lifestyle apps

Introduction

Cardiovascular disease (CVD) is the leading cause of death in the United States (US) and the world. One in five deaths in the US resulted from CVD in 2021, while one in three deaths worldwide resulted from CVD in 2019.^1,2 Approximately half of Americans (47%) have at least one of the five major CVD risk factors: hypertension, diabetes mellitus, dyslipidemia, obesity, and physical inactivity.^3,4 The prevalence of these CVD risk factors is 46%, 15%, 11%, 42%, and 25% in the US,^5–13 with similar prevalence trends of 31%, 8%, 39%, 13%, and 29% worldwide, respectively.

Recognizing the many health benefits of physical activity, professional organizations such as the American Heart Association (AHA), American College of Cardiology, American College of Sports Medicine (ACSM), and World Health Organization recommend exercise as the most efficient, cost-effective, and accessible “polypill” to prevent and treat CVD and its risk factors.^14–21 Despite these strong endorsements of exercise for heart health, only 30% of primary care physicians recommend exercise to their patients although such recommendations are a strong incentive for patients to exercise.^22–28 Recent studies identified the three primary barriers for physicians and other healthcare providers to prescribe exercise to be due to lack of tools, training, and time.^22,23,29,30 Indeed, fewer than half of the physicians in the US who finished training before 2013 received formal education in physical activity and/or exercise.²²

An ExRx is the process whereby an individualized physical activity program is structured by Frequency (How Often?), Intensity (How Hard?), Time (How Long?), and Type (What Kind?) principle of exercise or FITT. Personalized ExRxs are preferred over generic approaches to ExRx such as telling patients to walk to optimize health outcomes.^29,31–33 Indeed, the ACSM recommends different FITT ExRxs for 26 clinical chronic diseases and health conditions including the major CVD risk factors of hypertension, diabetes mellitus, dyslipidemia, and obesity.^21,34–36 Clinical decision support systems are rapidly growing tools in health care because they guide healthcare providers to streamline information, produce evidence-based diagnostics and prescriptions, recommend next steps of treatments, maintain long-term health management plans, and save time.^37–40 A well-developed clinical decision support system has the potential to overcome the barriers for clinicians to prescribe personalized ExRx for their patients.⁴¹ Accordingly, we performed a comprehensive systematic review of commercially available digital applications to determine if evidenced-based, time-efficient ExRx clinical decision support tools existed on the market.⁴² We found no such ExRx tool existed that addressed the primary barriers physicians face in prescribing exercise to their patients and that focused on CVD risk factors.⁴³

To address this unmet clinical need for an evidenced-based, time-efficient ExRx clinical decision support system, we integrated: 1) the ACSM exercise preparticipation health screening recommendations²¹; 2) an adapted AHA Life's Essential 8 cardiovascular health scoring system for untreated and treated CVD risk factors to determine the CVD risk factor posing the greatest heart health risk^43,44; 3) the ACSM strategies for designing an ExRx for healthy people with multiple CVD risk factors²¹; and 4) the ACSM FITT principle of ExRx, into a clinical decision support system, named Prioritize Personalize Prescribe Exercise algorithm (P3-EX), that Prioritizes Personalize Prescribes EXercise for individuals with multiple CVD risk factors. The purpose of this study is to test the usability and feasibility of P3-EX with a validated survey as an ExRx algorithm for clinicians to use among healthy adults with CVD risk factors.

Methods

The University of Connecticut Institutional Review Board declared this study exempt under category 45 CFR 46.104 (d) (2) as research that only included survey procedures that obtain information recorded by the investigator such that the identity of the human subjects cannot readily be ascertained, directly or through identifiers linked to the subjects. Specifically, because the study was exempted, the University of Connecticut Institutional Review Board approved subjects to provide informed consent through the study website as written informed consent was waived. From March 22, 2022 to January 30, 2023, we recruited as many healthcare providers (including physicians, nurses, physician assistants, exercise physiologists, and nutritionists who worked in hospitals) and other professionals working in healthcare-related fields (including biotechnology/pharmaceutical industry, health insurance, corporate/medical wellness, concierge medicine, clinical research, medical health education, and sports medicine) as needed to complete 300 study participants. All the recruitment was completed online. We posted study recruitment information in newsletters from professional organizations worldwide and at professional meetings and presentations. We also emailed study invitations to potential participants within the investigators’ professional networks. In addition, being employed in the professional disciplines above, study participants qualified if they had experience and/or an interest in recommending exercise to patients or clients. The inclusion criteria were: 1) is currently employed or past employed in the healthcare-related professional disciplines described above; and 2) experienced in and/or have an interest in recommending exercise to patients or clients.

During recruitment, we emailed the study invitation to participants, through which participants directly visited the study website. Once on the website, participants read detailed information about the study, provided informed consent, and completed the study within about 25 min. Participants completed the study using the web-based P3-EX algorithm containing a case study constructed by study investigators of a patient who was healthy other than having CVD risk factors that were posted on the study website. The case study included the following information: age, gender, smoking and exercise habits, CVD risk factors, medications, presence of signs and symptoms of CVD, diabetes mellitus, or renal disease, family history of chronic disease and health conditions, and the patient's exercise goals (see Supplement 1 for the case study). After reading the case study, the participants entered information on age, gender, and the presence of signs and symptoms of CVD, metabolic disease, and renal disease, and the desired exercise intensity. From the information entered, the web-based P3-EX algorithm determined if medical clearance was necessary before exercise participation based on the guidance of the ACSM.¹

Then, participants entered information on the CVD risk factors, including BMI, waist circumference, blood pressure, blood glucose, blood lipids–lipoproteins, and medications taken for any CVD risk factor, if any, into the web-based P3-EX algorithm. The web-based P3-EX algorithm then scored the CVD risk factors using the cardiovascular health risk scoring system adapted from the AHA's Life's Essential 8 that the investigators modified based upon the CVD risk factor being treated or not treated with medications.^43,44 Study participants then applied the ACSM's ExRx strategies for people with multiple CVD risk factors²¹ to prioritize the CVD risk factor posing the greatest cardiovascular health risk. Last, the web-based P3-EX algorithm produced a personalized FITT ExRx for that prioritized CVD risk factor. See Figure 1 and Figure 2 for the workflow of the P3-EX algorithm. Further details on the algorithm have been published elsewhere.⁴⁴ The time spent from participants first entering information from the case study into the web-based P3-EX algorithm to producing the personalized FITT ExRx was automatically recorded.

Figure 1.

Steps in the workflow of the web-based Prioritize Personalize Prescribe Exercise (P3-EX) algorithm.

Figure 2.

Screenshots of the steps in the workflow of the web-based Prioritize Personalize Prescribe Exercise (P3-EX) algorithm.

Next the participants completed a survey to evaluate the usability and feasibility of the web-based P3-EX algorithm. The study adapted a previously validated survey, named the Mobile Application Rating Scale,^45,46 that contained a scale to determine the usability of mobile apps for diabetes management which is a CVD risk factor, and a scale to evaluate the quality of mobile health apps across four dimensions: engagement, functionality, aesthetics, and information quality. We modified the survey by removing questions: 1) about aspects of an app not related to usability and feasibility (e.g., if the app is entertaining); and 2) not applicable to the functions of the web-based P3-EX algorithm. In addition, diabetes-specific contents of the Mobile Application Rating Scale^45,46 was replaced with CVD risk factor and ExRx specific contents. Participants responded to each survey question with a number range from 5 (completely agree) to 1 (completely disagree). Participants were not asked to provide reasons for their choice of number. In addition, participants’ demographic information was also collected by the adapted survey (see Supplement 2 for the adapted survey). Of note, the journal the survey was published in is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium. In addition, we have obtained the permission from the copyright holder to use this questionnaire in this study (see Supplement 2 and Supplement 3 for more detail).

Statistical analysis

We used descriptive statistics to calculate the % range of response for each survey question, time spent using the web-based P3-EX algorithm, and the FITT ExRx produced. We then performed a series of chi-square tests to test the associations among participants responses to each of survey questions and their gender, professional background (i.e., healthcare provider vs. other healthcare-related profession), and if the participant met the physical activity guidelines, recommended exercise to their patients, and worked directly with patients. We also performed chi-square tests to test if there were differences between the ACSM ExRx strategy used to prioritize the CVD risk factor and final ExRx FITT produced. In addition, we performed a logistic regression with no covariates to investigate the association between actual time spent to prioritize the CVD risk factor using the web based P3-EX algorithm and the level of participant agreement that using the web-based P3-EX algorithm would save time then when recommending exercise to their patients. All statistical analyses were done using IBM SPSS Statistics (28.0.0.0).

We also performed a post hoc power analysis to compute the achieved power of this study with 309 participants. We used G*Power (3.1.9.4),⁴⁷ with the following inputs: statistical test = means: difference from constant (one sample case); tails = 2; effect size d = 8; α error prob = 0.05; and total sample size = 309. The calculated critical t is 1.97 and the power of this study is 1.00.

Results

We sent recruitment email invitations to 844 potential participants. Of these, 309 (36.6%) agreed to participate and all completed the study. Of these, 143 (46.3%) were healthcare providers (see Table 1 for the breakdown of healthcare provider professions), while the remainder were working in the fields of: 1) biotechnology or the pharmaceutical industry (N = 28, 9.1%); 2) health insurance (N = 20, 6.5%); 3) corporate/medical wellness (N = 23, 7.4%); 4) concierge medicine (N = 21, 6.8%); 5) clinical research (N = 24, 7.8%); 6) medical health education (N = 30, 9.7%); or 7) sports medicine (N = 20, 6.5%). The participants were mostly middle-aged (41.0 ± 13.0 years), white (70.2%) females (60.4%) who worked in the US (86.7%) and met the physical activity guidelines for Americans from the U.S. Department of Health and Human Services (92.5%) (Table 1).

Table 1.

The participant demographic information.

Age	41.0 ± 13.0 years
Gender	Female (N = 187, 60.4%) Male (N = 118, 38.3%) Did not answer (N = 4, 1.3%)
Ethnicity and race	White (N = 217, 70.2%) Asian (N = 48, 15.5%) Hispanic or Latino (N = 23, 7.4%) African American (N = 20, 6.5%) American Indian or Alaska Native (N = 1, 0.3%)
Location of work	United States (N = 268, 86.7%) Did not answer, or N/A (N = 24, 7.8%) China (N = 9, 2.9%) Canada (N = 4, 1.3%) India (N = 1, 0.3%) Japan (N = 1, 0.3%) Portugal (N = 1, 0.3%) South Africa (N = 1, 0.3%)
Worked with patients directly	Work with patients directly (N = 223, 72.3%) Do not work with patients directly (N = 80, 25.9%) Did not answer (N = 6, 1.8%)
Met the physical activity guidelines*	Yes (N = 286, 92.5%) Did not answer (N = 13, 4.2%) No (N = 10, 3.2%)
Profession breakdown of healthcare providers	Physician (N = 102, 71.3%) Nurse (N = 15, 10.5%) Clinical exercise physiologist (N = 11, 7.7%) Physician assistant (N = 9, 6.3%) Clinical dietitian (N = 6, 4.2%)

*At least 150 min of moderate intensity physical activity or 75 min of vigorous intensity physical activity per week cumulatively.⁴⁸

The first series of questions on the survey inquired about the participants’ general satisfaction using the web-based P3-EX algorithm (Table 2, question 1–3). Most participants (80.4%) were satisfied with using the web-based P3-EX algorithm and would use it with their patients (73.3%) and recommend it to their colleagues (92.6%) when it becomes an app.

Table 2.

The survey questions by percent of participants’ (n) answers for each of the five possible responses.

Question	Strongly agree	Somewhat agree	Neutral	Somewhat disagree	Strongly disagree
Series 1: General satisfaction
1. Overall, I am satisfied with P3-EX.	43.5% (117)	37.9% (102)	10.4% (28)	5.9% (16)	2.2% (6)
2. I would use P3-EX with my patients when it becomes an app.	42.2% (95)	31.1% (70)	14.7% (33)	5.8% (13)	6.2% (14)
3. I would recommend P3-EX to my colleagues when it becomes an app.	63.2% (144)	29.4% (67)	13.2% (30)	4.8% (11)	2.6% (6)
Series 2: Perceived ease of use
4. I think the logic of the P3-EX is easy to follow.	59.4% (167)	26.0% (73)	7.2% (20)	6.0% (17)	1.4% (4)
5. I think P3-EX is intuitive.	48.7% (136)	34.7% (97)	8.2% (23)	6.4% (18)	2.1% (6)
6. I think the wording in P3-EX is easy to understand.	53.7% (153)	33.3% (95)	9.1% (26)	1.8% (5)	2.1% (6)
7. I think the images and tables in P3-EX are easy to understand.	44.6% (127)	35.1% (100)	10.2% (29)	3.2% (9)	7.0% (20)
8. I think the click sensitive areas in P3-EX are easy to recognize.	63.7% (177)	25.5% (71)	3.2% (9)	5.0% (14)	2.5% (7)
9. I think the feedback provided by P3-EX is instant and understandable.	53.2% (151)	33.6% (97)	7.3% (21)	4.9% (14)	1.0% (3)
Series 3: Easiness to the eye
10. I think the color contrast in P3-EX is easy on my eyes.	47.2% (136)	32.6% (94)	10.4% (30)	4.9% (14)	3.5% (10)
11. I think the size of the screen and the input fields in the P3-EX are large enough.	55.7% (160)	35.5% (102)	5.6% (16)	2.1% (6)	1.0% (3)
Series 4: Practicality
12. I think the fault tolerance of P3-EX was high enough.	38.7% (105)	29.5% (80)	23.2% (63)	6.4% (17)	2.2% (6)
13. P3-EX can save me time when I prescribe exercise to my patients.	38.7% (105)	29.5% (80)	23.2% (63)	6.4% (17)	2.2% (6)
14. When using P3-EX, there is minimal risk in ExRx to my patients.	43.6% (95)	36.2% (65)	16.0% (35)	2.8% (6)	1.4% (3)

Note: Participants who answered N/A or did not answer were not included in percentage calculations.

P3-EX: Prioritize Personalize Prescribe Exercise.

The second series of questions on the survey asked for the participants’ perceived ease of use of the web-based P3-EX algorithm (Table 2, question 4–9). Most participants (85.4%) agreed the web-based P3-EX algorithm was intuitive and the logic of it was easy to follow (83.4%) (Table 2, questions 4 and 5). In addition, the wording (87.0%), images and tables (79.7%), and click sensitive areas (89.2%) were all perceived as easy to recognize and understood by most of the participants. Last, when asked if the feedback provided by P3-EX was instant and understandable, 86.8% of the participants agreed (Table 2, question 9).

The third series of questions on the survey asked about the participants’ perceived ease to the eye of the web-based P3-EX algorithm (Table 2, question 10–11). Most of the participants felt the color contrast was easy on eyes (79.8%), and the size of the screen and input fields were large enough (90.2%).

The fourth series of questions on the survey asked about the practicality of the web-based P3-EX algorithm (Table 2, questions 12–14). Most of the participants agreed that the fault tolerance of P3-EX was high enough (68.2%), 73.9% agreed P3-EX could save them time when prescribing exercise to their patients, and 79.8% agreed the risk of using P3-EX to patients was minimal. The average time spent using P3-EX to produce the personalized FITT ExRx was 4.6 + 1.8 min.

We performed a series of chi-square tests to examine the associations among participants’ characteristics and their responses to each of the 14 questions. The responses did not differ by gender, if the participants directly worked with their patients or not, and if they regularly recommended exercise to patients or not (all ps > 0.5). The frequency by which participants agreed that they would recommend the web-based P3-EX algorithm to their colleagues differed by profession (p = 0.029) such that 75.9% (N = 82) of healthcare providers agreed, whereas 87.2% (N = 102) of participants working in other professions agreed. Last, we performed a logistic regression to investigate the association between time spent in P3-EX and whether using P3-EX would save time (Table 2, question 13). The participants who spent more time using the web-based P3-EX algorithm to produce the personalized FITT ExRx were more likely to disagree that it saved them time (p < 0.01).

Figure 3 displays the percentage of participants that selected the ACSM's exercise prescription strategies to prioritize the CVD risk factor to focus the FITT ExRx. Over half (54.0%, N = 167) of the participants chose ACSM Strategy C, which was the ExRx that encompasses most of the FITT ExRx for the other CVD risk factors; 12.0% chose ACSM Strategy B, which was the most conservative ExRx regarding intensity and/or volume; and 34.0% chose ACSM Strategy A, which was the ExRx that focused on the CVD risk factor that is the most limiting regarding activities of daily living and/or quality of life. Of the CVD risk factors that the patient had, independent of the ACSM Strategy used, hypertension was prioritized by most of the participants (77.9%) followed by dyslipidemia 12.9%, and obesity 7.1%. However, depending on the ACSM ExRx strategy chosen, the frequency of the CVD risk factor prioritized to focus the ExRx differed (p < 0.001). When using ACSM Strategy A, hypertension was prioritized by most of the participants (83.8%) followed by obesity (13.3%) and dyslipidemia (2.9%). When using ACSM Strategy B dyslipidemia was prioritized by most of the participants (78.4%) followed by obesity (13.5%) and hypertension (8.1%). When choosing ACSM Strategy C, hypertension was prioritized by most of the participants (93.4%) followed by dyslipidemia (4.8%) and obesity (4.8%).

Figure 3.

The percentage of participants (n) that selected the ACSM's exercise prescription strategies to prioritize the cardiovascular disease risk factor to focus the FITT ExR.

Discussion

This study tested the feasibility of P3-EX, particularly user satisfaction and usability, as an ExRx tool for healthcare professionals to use for patients with CVD risk factors. The results demonstrated P3-EX had consistently high and favorable participant responses regarding their satisfaction with and usability of P3-EX as an ExRx tool for patients with CVD risk factors. Indeed, 80–90% of the 309 respondents agreed that P3-EX was intuitive, producing high-quality, evidenced-based, individualized ExRx; using P3-EX would make their patients healthier; feedback was immediate and understandable; and they would recommend P3-EX to their colleagues and were satisfied with P3-EX. In addition, over 70% of the respondents agreed P3-EX was safe, would save them time when prescribing exercise, and they would use P3-EX with their patients.

The average time it took the respondents to produce the personalized ExRx using P3-EX was 4 min and 32 s with a standard deviation of 1 min and 45 s. However, when considering only the health care providers, the time for completion was a minute less than that of the overall sample. The average time of a doctor's visit in the US is 17.4 min.⁴⁹ Thus, at present, using P3-EX would take 20–25% of the time when the doctor is visiting with the patient. Although there are no data on how much time doctors can allocate to a new task during standard of care, P3-EX should be further streamlined to reduce usage time when developing the minimum viable product for go-to-market testing. Another feature of P3-EX that could be improved is fault tolerance which is the ability of P3-EX to run without interruption.⁵⁰ Fault tolerance has a profound impact on the success of an mHealth app by directly affecting: 1) the average time to complete a task, 2) the accuracy of the app, and 3) user satisfaction in general.^51,52 Therefore, P3-EX should also consider improving fault tolerance of P3-EX when developing the minimum viable product for go-to-market testing to also improve the time to completion.

The final product of P3-EX is an individualized, comprehensive FITT ExRx that focuses on a prioritized chronic disease or health condition.⁴² In our feasibility survey study, participants were given the same case study that had the following CVD risk factors: obesity, hypertension, and dyslipidemia (Supplement 1). Although respondents selected different ACSM ExRx strategies to focus the FITT ExRx, 80% selected hypertension to focus the FITT ExRx followed by 13% selecting dyslipidemia and 7% obesity. Using the ACSM strategies to focus the FITT ExRx on a given chronic disease or health condition is a matter of clinical decision making.⁴⁴ Nonetheless, choosing hypertension to be the health condition/ CVD risk factor to focus the FITT ExRx was remarkedly consistent among our sample.

Despite our systematic review of the literature, we were unable to find an established cutoff value to rate inter-user consistency for mHealth apps.^42,53 Therefore, we compared the results of our feasibility survey study to a similar study by Marinus et al.⁵¹ In their study, 47 physiotherapists were provided with three of the same case studies and prescribed a FITT ExRx for each. The investigators found a very wide inter-user variability in all elements of the FITT ExRx prescribed and low levels of agreement with the professional guidelines for patients with CVD.⁵⁴ For example, the prescribed frequency of exercise ranged from two to seven times per week and time per session ranged from 20 to 120 min.⁵⁵ Foccardi et al. provided 26 general practitioners with a standardized clinical case to evaluate their ExRx skills. When the researchers compared the general practitioners’ prescribed ExRx to the professional guidelines, exercise frequency and intensity were under-dosed, and there was significant heterogeneity in the prescription of exercise type with resistance exercise generally not prescribed. Specifically, the prescribed frequency ranged from one to seven times per week; time per session ranged from 20 to 60 min; and 8% of the general practitioners prescribed vigorous exercise, 42% prescribed moderate, and 46% prescribed light intensity.⁵⁴ Of note, the general practitioners in this study rated their ExRx skills as insufficient, and they would welcome a guidelines-based digital decision support tool to use in their practice such as P3-EX to improve patient outcomes.^29,54

Our findings indicate there are important considerations as the P3-EX minimum viable product is developed for future testing. One is the diversity of the participants in terms of race/ethnicity and place of work. In our study ∼30% of respondents belonged to minor ethnicity and racial groups, while 70% were white (Table 2). Moreover, 87% of respondents worked in the US, while only 13% worked in countries outside of the US (Table 2). To generate a deeper and wider understanding of the feasibility of P3-EX, future work should involve participants from underrepresented ethnicity and racial groups nationally and internationally. Most of the respondents in our study met or exceeded the amount of physical activity recommended in the Physical Activity Guidelines for Americans (Table 2).⁴⁸ Because physically active health care providers are more likely to recommend exercise to patients,²⁴ having an overall physically active sample may limit the generalizability of our findings. To avoid similar limitations, future work should include a less physically active sample.

Despite our positive findings, we plan to continue to improve the functionality of P3-EX in the following ways. First, is to improve the design of graphs and tables because the respondents rated them the most unfavorably, that is, “strongly disagree”, among all questions in the survey (Table 2). Second, is to test the feasibility of the algorithm under specific real-world test settings with patients. Third, is to enhance the scalability of P3-EX so that its function will include services targeting clinical populations with other chronic diseases and health conditions, other lifestyle behaviors such as diet, behavioral prompts, real-time monitoring with wearables such as electrocardiographic monitoring for patients in cardiac rehabilitation.

Our study has several strengths. The first is its ability to collect and analyze data from a large sample of 309 respondents. Although we did not perform a priori sample size power calculation, our post-hoc power calculation indicated the study was more than adequately powered. Furthermore, the large sample size of this study is generally uncommon among health care app evaluation survey studies that typically have samples ranging in size from 45 to 115 participants.⁵⁵ In addition, as far as we are aware, we are the first study design to purposefully include participants from eight different types of professionals working in healthcare and healthcare related fields⁵⁶ enabling us to capture a wide range of perspectives on the feasibility of P3-EX. Last, based on our recently published systematic review of publicly available digital exercise applications, no app on the market covered the evidence-based functions and P3-EX does.^42,56

Conclusion

We found that healthcare professionals and professionals working in healthcare related fields consistently rated P3-EX favorably regarding usability and user satisfaction, being well received as a digital ExRx tool to be used in clinical practice. P3-EX meets an unmet clinical need; nonetheless, fault tolerance and the time to completion can be improved when developing the minimum viable product for future market testing.

Supplemental Material

sj-docx-1-dhj-10.1177_20552076251360884 - Supplemental material for An exercise prescription algorithm for clinicians to use with their patients with cardiovascular disease risk factors

Supplemental material, sj-docx-1-dhj-10.1177_20552076251360884 for An exercise prescription algorithm for clinicians to use with their patients with cardiovascular disease risk factors by Shiqi Chen, Yin Wu, Justin Kennedy, Gregory Panza, Margaux Zwierko Guidry, Linda S Pescatello and in DIGITAL HEALTH

Supplemental Material

sj-docx-2-dhj-10.1177_20552076251360884 - Supplemental material for An exercise prescription algorithm for clinicians to use with their patients with cardiovascular disease risk factors

Supplemental material, sj-docx-2-dhj-10.1177_20552076251360884 for An exercise prescription algorithm for clinicians to use with their patients with cardiovascular disease risk factors by Shiqi Chen, Yin Wu, Justin Kennedy, Gregory Panza, Margaux Zwierko Guidry, Linda S Pescatello and in DIGITAL HEALTH

Footnotes

ORCID iD

Shiqi Chen

Ethical considerations

This study is determined to qualify for exemption, and thus approved by the University of Connecticut Institutional Review Board on February 18, 2021. The referral number is X21-000.

Author contributions

Shiqi Chen contributed in the following ways: 1) concept, design, and data interpretation; 2) recruitment; 3) drafting of the manuscript; 4) coding of P3-EX algorithm; and 5) final approval. Yin Wu, and Linda Pescatello contributed to this systematic review in the following ways: 1) concept, design, and data interpretation; 2) recruitment; 3) drafting of the manuscript; and 4) final approval. Justin Kennedy contributed in the following ways: 1) coding of P3-EX algorithm. Gregory Panza and Margaux Guidry contributed in the following ways: 1) concept, design, and data interpretation; and 2) recruitment.

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Declaration of conflicting interests

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Linda Pescatello is the owner of P3-EX LLC, a software company that prioritizes, prescribes, and personalizes exercise (P3-EX) for individuals with cardiovascular disease (CVD) risk factors, and inventor of the intellectual property (IP) of P3-EX which could benefit from this research.

Guarantor

LSP.

Supplemental material

Supplemental material for this article is available online.

References

Centers for Disease Control and Prevention. Heart Disease Facts. Available online: https://www.who.int/health-topics/cardiovascular-diseases (accessed 4 January 2024).

World Health Organization. Cardiovascular diseases. Available online: https://www.cdc.gov/heartdisease/facts.htm (accessed 4 January 2024).

Martin

Aday

Almarzooq

, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 Heart Disease and Stroke Statistics: a report of US and Global Data from the American Heart Association. Circulation. 2024; 149: e347–e913. Epub 2024 Jan 24. Erratum in: Circulation. 2024 May 7;149(19):e1164.

Centers for Disease Control and Prevention. Know Your Risk for Heart Disease. Available online: https://www.cdc.gov/heartdisease/risk_factors.htm (accessed 4 January 2024).

Mills

Stefanescu

. The global epidemiology of hypertension. Nat Rev Nephrol 2020; 16: 223–237.

World Health Organization. Diabetes. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed 4 January 2024).

Centers for Disease Control and Prevention. National Diabetes Statistics Report. Available online: https://www.cdc.gov/diabetes/data/statistics-report/index.html (accessed 4 January 2024).

World Health Organization. Raised cholesterol. Available online: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3236 (accessed 4 January 2024).

Carroll

Fryar

. Total and high-density lipoprotein cholesterol in adults: United States, 2015–2018. NCHS Data Brief, no 363. Hyattsville, MD: National Center for Health Statistics, 2020.

10.

World Health Organization. Obesity and overweight. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed 4 January 2024).

11.

Centers for Disease Control and Prevention. Adult Obesity Facts. Available online: https://www.cdc.gov/obesity/data/adult.html (accessed 4 January 2024).

12.

World Health Organization. Global Status Report on Physical Activity 2022. Let’s go moving! Available online: https://www.who.int/teams/health-promotion/physical-activity/global-status-report-on-physical-activity-2022 (accessed 4 January 2024).

13.

Centers for Disease Control and Prevention. Adult Physical Inactivity Prevalence Maps by Race/Ethnicity. Available online: https://www.cdc.gov/physicalactivity/data/inactivity-prevalence-maps/index.html (accessed 29 July 2022).

14.

Martin

Aday

Almarzooq

, et al. American Heart Association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024; 149: e347–e913. Epub 2024 Jan 24. Erratum in: Circulation. 2024 May 7;149(19):e1164.

15.

Booth

Roberts

Laye

. Lack of exercise is a major cause of chronic diseases. Compr Physiol 2012; 2: 1143–1211.

16.

Colberg

Sigal

Yardley

. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016; 39: 2065–2079.

17.

Grundy

Stone

Bailey

. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary. Circulation 2018; 73: 3168–3209.

18.

Physical Activity Guidelines Advisory Committee. U.S. Department of Health and Human Services; Washington, DC: 2018. 2018 Physical Activity Guidelines Advisory Committee Scientific Report.

19.

Stone

Robinson

Lichtenstein

. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014; 129: S1–S45.

20.

Whelton

Carey

Aronow

. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension 2018; 71: e13–e115.

21.

American College of Sports Medicine; Gary, L. ACSM’s Guidelines for Exercise Testing and Prescription, 11th ed.; Wolters Kluwer: Philadelphia, PA, USA, 2021.

22.

American College of Sports Medicine Exercise is Medicine. www.exerciseismedicine.org. 2018 (accessed 10 December 2023).

23.

Barnes

Schoenborn

. Trends in adults receiving a recommendation for exercise or other physical activity from a physician or other health professional. NCHS Data Brief 2012; 86: 1–8.

24.

Selvaraj

Abdullah

. Physically active primary care doctors are more likely to offer exercise counselling to patients with cardiovascular diseases: a cross-sectional study. BMC Prim Care 23 2022; article number 59.

25.

O'Regan

Pollock

D'Sa

, et al. ABC of prescribing exercise as medicine: a narrative review of the experiences of general practitioners and patients. BMJ Open Sport Exerc Med 2021; 7: e001050.

26.

Myles

Christopher

Paul

, et al. Health care provider confidence and exercise prescription practices of exercise is medicine Canada workshop attendees. Appl Physiol Nutr Metab 2017; 42: 384–390.

27.

Callum

Kirstin

Blair

. Narrative review – barriers and facilitators to promotion of physical activity in primary care. Lifestyle Med 2023; 4: e81.

28.

Leemrijse

De Bakker

Ooms

, et al. Collaboration of general practitioners and exercise providers in promotion of physical activity a written survey among general practitioners. BMC Fam Pract 2015; 16: 91.

29.

Hansen

Rovelo

Doherty

. Do clinicians prescribe exercise similarly in patients with different cardiovascular diseases? Findings from the EAPC EXPERT working group survey. Eur J Prev Cardiol 2018; 25: 682–691.

30.

Thompson

Eijsvogels

TMH

. New physical activity guidelines: a call to activity for clinicians and patients. JAMA 2018; 320: 1983–1984.

31.

Hanssen

Boardman

Deiseroth

, et al. Personalized exercise prescription in the prevention and treatment of arterial hypertension: a consensus document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on hypertension. Eur J Prev Cardiol 2022; 29: 205–215.

32.

Kuerschner

Kirton

Dalleck

, et al. The impact of individualised versus standardised endurance and resistance training on the fitness-fatness index in inactive adults. J Sci Med Sport 2024; 27: 326–332.

33.

Maslov

Schulman

Lavie

, et al. Personalized exercise dose prescription. Eur Heart J 2018; 39: 2346–2355.

34.

Kemps

Kränkel

Dörr

, et al. Exercise training for patients with type 2 diabetes and cardiovascular disease: what to pursue and how to do it. A position paper of the European association of preventive cardiology. Eur J Prev Cardiol 2019; 26: 709–727.

35.

Jean-Michel

Alice

Marleen

, , et al. Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European association for the study of obesity physical activity working group. Obes Rev 2021; 22: e13273.

36.

Dominique

Karin

Paul

, , et al. Appropriate exercise prescription in primary and secondary prevention of cardiovascular disease: why this skill remains to be improved among clinicians and healthcare professionals. A call for action from the EXPERT network. Eur J Prev Cardiol 2023; 30: 1986–1995.

37.

Shortliffe

Sepulveda

. Clinical decision support in the era of artificial intelligence. JAMA 2018; 320: 2199–2200.

38.

Zaleski

Berkowsky

Craig

KJT

, et al. Comprehensiveness, accuracy, and readability of exercise recommendations provided by an AI-based chatbot: mixed methods study. JMIR Med Educ 2024; 10: e51308.

39.

Milosevic

Jin

Singh

, et al. Applications of AI in multi-modal imaging for cardiovascular disease. Front Radiol 2024; 3: 1294068.

40.

Omiye

Ghanzouri

Lopez

, et al. Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events. PLoS One 2024; 19: e0303610.

41.

Whitelaw

Pellegrini

Mamas

, et al. Barriers and facilitators of the uptake of digital health technology in cardiovascular care: a systematic scoping review. Eur Heart J Digit Health 2021; 2: 62–74.

42.

Chen

Bushey

, et al. Evaluation of exercise Mobile applications for adults with cardiovascular disease risk factors. J Cardiovasc Dev Dis 2023; 10: 77.

43.

American Heart Association Life’s Essential 8. Available online: https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8 (accessed 22 April 2023).

44.

Linda

Yin

Gregory

, et al. Development of a novel clinical decision support system for exercise prescription among patients with multiple cardiovascular disease risk factors. Mayo Clin Proc Innov Qual Outcomes 2021; 5: 193–203.

45.

Stoyanov

Hides

Kavanagh

, et al. Development and validation of the user version of the Mobile application rating scale (uMARS). JMIR Mhealth Uhealth 2016; 4: e72.

46.

Terhorst

Philippi

Sander

, et al. Validation of the Mobile application rating scale (MARS). PLoS One 2020; 15: e0241480.1.

47.

Faul

Erdfelder

Lang

A-G

, et al. G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39: 175–191.

48.

Piercy

Troiano

Ballard

, et al. The physical activity guidelines for Americans. JAMA 2018; 320: 2020–2028.

49.

Neprash

Mulcahy

Cross

, et al. Association of primary care visit length with potentially inappropriate prescribing. JAMA Health Forum 2023; 4: e230052.

50.

Balbastro

Capozucca

Guelfi

. Analysis and framework-based design of a fault-tolerant web information system for m-health. Serv Orient Comput Appl 2008; 2: 111–144.

51.

Albahri

Zaidan

Albahri

, et al. Real-time fault-tolerant mHealth system: Comprehensive review of healthcare services, opens issues, challenges and methodological aspects. J Med Syst 2018; 42: 137.

52.

Mohsin

Naqvi

SIR

Khan

, et al. A comprehensive framework to quantify fault tolerance metrics of web centric mobile applications. In 2017 international conference on communication technologies (comtech) (65-71). IEEE. 2017.

53.

Bushey

Wright

, et al. The influence of physical activity and diet Mobile apps on cardiovascular disease risk factors: meta-review. J Med Internet Res 2024; 26: e51321.

54.

Giulia

Dominique

Giulia

, et al. How do general practitioners assess physical activity and prescribe exercise in patients with different cardiovascular diseases? An Italian pilot study. Eur J Prevent Cardiol 2021; 28: e20–e24.

55.

Marinus

Cornelissen

Meesen

, et al.

Are exercise prescriptions for patients with cardiovascular disease, made by physiotherapists, in agreement with European recommendations?

Eur J Cardiovasc Nurs 2024; 23: 230–240.

56.

Eisenstadt

Liverpool

Metaxa

, et al. Acceptability, engagement, and exploratory outcomes of an emotional well-being app: mixed methods preliminary evaluation and descriptive analysis. JMIR Form Res 2021; 5: e31064.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB

0.11 MB